S2B Syn2bio S.A.

13.43USD53.98 PLN · GPW-2.56%Mkt Cap: 120.35M USDP/E: —

Syn2bio S.A. operates as a biotechnology company. It engages in the development and commercialization of SYN2 cardiotracer, a radiopharmaceutical designed for testing myocardial perfusion and diagnosis of coronary artery…